Fresenius MedCare: Barclays adjusts TP

(CercleFinance.com) - Barclays confirms its 'equal weight' recommendation on Fresenius Medical Care shares, nudging up its TP from E38.
5 to E39, citing the German dialysis specialist's latest quarterly publication.

"Turnaround is on track, with pricing and savings driving a stronger than expected print in Care Enablement EBIT", the broker points out.

"Weaker same-store growth was a focus for investors, came as a disappointment, though should be the trough in the year, Barclays adds.


Copyright (c) 2024 CercleFinance.com. All rights reserved.
The information and analyses distributed by Cercle Finance are only intended as decision-making support for investors. Cercle Finance's responsibility may not be entailed, either directly or indirectly following the use of such information and analyses by readers. Any non-professional investor is recommended to consult a professional advisor before making any investment decision. This indicative information in no way constitutes any invitation to sell or buy securities.
The information and analyses published by Cercle Finance are intended solely as a decision-making aid for investors. Cercle Finance cannot be held responsible, directly or indirectly, for the use of information and analyses by readers. Uninformed investors are advised to consult a professional advisor before investing. This information does not constitute an invitation to sell or a solicitation to buy.